Practically scheduling hormone therapy for prostate cancer using a mathematical model

J Theor Biol. 2019 Oct 7:478:48-57. doi: 10.1016/j.jtbi.2019.06.012. Epub 2019 Jun 13.

Abstract

Hormone therapy is one of the popular therapeutic methods for prostate cancer. Intermittent androgen suppression (IAS) is the method which stops and resumes hormone therapy repeatedly. The efficacy of IAS differs depending on patients; both the cases have been reported where the relapse of cancer happened and did not happen, for the patients who had undergone IAS. For the patients who cannot avoid the relapse of cancer by IAS, we should delay the relapse of cancer as later as possible. Here we compared some practical methods of determining when to stop and restart hormone therapy for IAS using an existing mathematical model of prostate cancer. The method we suggest is to determine the ratio of on-treatment period and off-treatment period sparsely for each cycle, namely the "sparse search." We also compared the performance of the sparse search with the exhaustive search and the model predictive control. We found that the sparse search can find a good treatment schedule without failure, and the computational cost is not so high compared to the exhaustive method. In addition, we focus on the model predictive control (MPC) method which has been applied to the scheduling of IAS in some existing studies. The MPC is computationary efficient, although it does not always find an optimal schedule in the numerical experiments here. We believe that the MPC method might be also promising because of its reasonable computational costs and its possibility of expanding of the model.

Keywords: Intermittent androgen suppression (IAS); Mathematical medicine; Mathematical model; Model predictive control (MPC).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Androgen Antagonists / therapeutic use*
  • Computer Simulation
  • Drug Administration Schedule
  • Humans
  • Male
  • Models, Biological*
  • Models, Theoretical*
  • Numerical Analysis, Computer-Assisted
  • Probability
  • Prostate-Specific Antigen / metabolism
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen